U.S. Markets closed
  • S&P 500

    4,686.75
    +95.08 (+2.07%)
     
  • Dow 30

    35,719.43
    +492.40 (+1.40%)
     
  • Nasdaq

    15,686.92
    +305.62 (+1.99%)
     
  • Russell 2000

    2,253.79
    +47.46 (+2.15%)
     
  • Crude Oil

    71.73
    -0.32 (-0.44%)
     
  • Gold

    1,784.90
    +0.20 (+0.01%)
     
  • Silver

    22.52
    +0.00 (+0.01%)
     
  • EUR/USD

    1.1274
    -0.0032 (-0.2818%)
     
  • 10-Yr Bond

    1.4800
    +0.0320 (+2.21%)
     
  • Vix

    21.89
    -6.06 (-21.68%)
     
  • GBP/USD

    1.3245
    -0.0057 (-0.4318%)
     
  • USD/JPY

    113.5240
    +0.3150 (+0.2782%)
     
  • BTC-USD

    50,266.82
    -662.70 (-1.30%)
     
  • CMC Crypto 200

    1,308.39
    -133.37 (-9.25%)
     
  • FTSE 100

    7,339.90
    +210.69 (+2.96%)
     
  • Nikkei 225

    28,455.60
    +702.20 (+2.53%)
     

U.S. government to buy point-of-care COVID-19 tests from Abbott, Celltrion -source

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Sept 21 (Reuters) - The U.S. government has agreed to purchase point-of care COVID-19 tests from Abbott Laboratories and Celltrion Inc to ship to nursing homes and other high risk populations as part of its broader plan to purchase $2 billion in rapid coronavirus tests, a person familiar with the matter said on Tuesday.

The federal government will purchase tests as needed and has agreed to spend up to $626 million in its agreement with Celltrion and $554.4 million in its deal with Abbott, the person said.

(Reporting by Carl O'Donnell Editing by Chris Reese)